Artigo
Revisado por pares
MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
2018; Elsevier BV; Volume: 68; Linguagem: Inglês
10.1016/s0168-8278(18)30292-7
ISSN1600-0641
AutoresStephen A. Harrison, Sam Moussa, Mustafa R. Bashir, Naim Alkhouri, José Aristeu Fachini Frias, Seth J. Baum, Brent A. Tetri, Meghana Bansal, Rebecca Taub,
Tópico(s)Liver Diseases and Immunity
Referência(s)